Cyclothiocarbamate derivatives as progesterone receptor modulators

ZHANG PUWEN, FENSOME ANDREW, TEREFENKO EUGENE A, HI LIN, JONES TODD K, TEGLEY CHRISTOPHER M, WROBEL JAYE, EDWARDS JAMES P, COLLINS MARK A
2004
OA: closed Metadata only

Abstract

A compound of formula (I) used for the treatment of carcinomas or adenocarcinomas of the endometrium, ovary, breast, colon or prostate dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, fibroids, or post menopausal hormone replacement therapy, and as a contraceptive.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-09T06:07:56.200469+00:00